GERN

GERON CORP

Sales chart range
Log in to watch GERN
Latest sale
$19k
Feb 18 · Unusual
Form 4 sales
93
On record
Form 144 notices
2
Proposed sales
Next unlock
None
No lockup ahead

Lockups

No lockup on record.

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Timeline

  1. 1 Form 4 saleRoutine
    May 11 2023

    Sold 35,000 shares at $3.00 ($105k)

    Lawlis V Bryan, Director

    10b5-1 planSold 100% of holdings ($105k position)0 shares leftFirst sale on recordFollows a Form 144Filing

  2. 2 Form 144 noticeNotice
    May 11 same day

    Filed to sell 35,000 shares ($105k)

    Lawlis V Bryan, Director

    10b5-1 planFirst sale on recordFiling

  3. 3 Form 4 saleRoutine
    May 15 +370 days

    Sold 35,000 shares at $3.75 ($131k)

    Lawlis V Bryan, Director

    10b5-1 planSold 100% of holdings ($131k position)0 shares leftFiling

  4. 4 Form 4 saleUnusual
    Jun 4 +20 days

    Sold 600,000 shares at $4.00 ($2.4M)

    Scarlett John A, Chairman, President and CEO

    No 10b5-1 planSold 50% of holdings ($4.8M position)600,000 shares leftFiling

  5. 5 Form 4 saleUnusual
    Jun 10 +6 days

    Sold 421,875 shares at $4.65 ($2M)

    Kapur Anil, EVP, Corp Strategy & CCO

    No 10b5-1 planSold 100% of holdings ($2M position)0 shares leftFirst sale on recordFiling

  6. 6 Form 4 saleUnusual
    Jun 10 same day

    Sold 287,900 shares at $4.63 ($1.3M)

    Feller Faye, EVP, Chief Medical Officer

    No 10b5-1 planSold 100% of holdings ($1.3M position)0 shares leftFirst sale on recordFiling

  7. 7 Form 4 saleUnusual
    Jul 8 +28 days

    Sold 674,348 shares at $4.56 ($3.1M)

    Grethlein Andrew J, EVP, Chief Operating Officer

    No 10b5-1 planSold 100% of holdings ($3.1M position)0 shares leftFiling

  8. 8 Form 4 saleUnusual
    Feb 18 +590 days

    Sold 9,855 shares at $1.94 ($19k)

    Robertson Michelle, EVP, CHIEF FINANCIAL OFFICER

    No 10b5-1 planSold 35.8% of holdings ($53k position)17,645 shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales, notices and lockups (95)

Export watchlist as CSV
Lockups, Form 144 notices and Form 4 sales for GERN
Source
Feb 18, 2026Robertson MichelleEVP, CHIEF FINANCIAL OFFICERForm 4 sale9,855$19k35.8%UnusualSEC
Jul 8, 2024Grethlein Andrew JEVP, Chief Operating OfficerForm 4 sale674,348$3.1M100.0%UnusualSEC
Jun 10, 2024Feller FayeEVP, Chief Medical OfficerForm 4 sale287,900$1.3M100.0%UnusualSEC
Jun 10, 2024Kapur AnilEVP, Corp Strategy & CCOForm 4 sale421,875$2M100.0%UnusualSEC
Jun 4, 2024Scarlett John AChairman, President and CEOForm 4 sale600,000$2.4M50.0%UnusualSEC
May 15, 2024Lawlis V BryanDirectorForm 4 sale35,000$131k100.0%RoutineSEC
May 11, 2023Lawlis V BryanDirectorForm 144 notice35,000$105kNoticeSEC
May 11, 2023Lawlis V BryanDirectorForm 4 sale35,000$105k100.0%RoutineSEC
May 1, 2023Molineaux SusanDirectorForm 4 sale35,000$87k100.0%UnusualSEC
May 1, 2023Molineaux SusanDirectorForm 144 notice35,000$87kNoticeSEC
Feb 10, 2023Scarlett John AChairman, President and CEOForm 4 sale1.3M$4.1M100.0%UnusualSEC
Feb 9, 2023Grethlein Andrew JEVP, Chief Operating OfficerForm 4 sale384,719$1.2M100.0%UnusualSEC
Feb 8, 2023Bloom Olivia KyusukEVP, Chief Financial OfficerForm 4 sale400,000$1.2M84.3%UnusualSEC
Apr 9, 2019Behrs Melissa KellyEVP, Chief Business OfficerForm 4 sale120,635$241k100.0%UnusualSEC
Sep 13, 2018Spiegel Robert J.DirectorForm 4 sale175,000$1.2M72.7%UnusualSEC
Aug 24, 2018Rosenfield StephenEVP, Genl Counsel & SecretaryForm 4 sale1.4M$6.1M100.0%UnusualSEC
May 29, 2015Bloom Olivia KyusukEVP, Chief Financial OfficerForm 4 sale2,380$9k3.1%Plan not statedSEC
May 29, 2015Behrs Melissa KellyEVP BD and Port&Alliance MgmtForm 4 sale2,380$9k1.9%Plan not statedSEC
Mar 18, 2015Hofstaetter ThomasDirectorForm 4 sale70,000$287k72.5%UnusualSEC
May 29, 2014Bloom Olivia KyusukEVP, Chief Financial OfficerForm 4 sale3,379$7k4.0%Plan not statedSEC
May 29, 2014Behrs Melissa KellyEVP Portfolio & Alliance MgmtForm 4 sale4,826$10k3.3%Plan not statedSEC
Apr 1, 2014Bloom Olivia KyusukEVP, Chief Financial OfficerForm 4 sale7,435$16k8.0%Plan not statedSEC
Apr 1, 2014Behrs Melissa KellyEVP Portfolio & Alliance MgmtForm 4 sale12,310$26k7.7%Plan not statedSEC
Jan 17, 2013Behrs Melissa KellySVP Alliance and Prog MgmtForm 4 sale28,292$47k100.0%UnusualSEC
May 30, 2012Kelsey Stephen MichaelEVP, R&D Head, CMOForm 4 sale9,300$13k1.9%Plan not statedSEC
May 30, 2012Earp DavidSVP, Corp TransactionsForm 4 sale27,155$37k5.5%Plan not statedSEC
May 30, 2012Bloom Olivia KyusukVP, Chief Acctg OfficerForm 4 sale11,029$15k6.9%Plan not statedSEC
May 30, 2012Behrs Melissa KellySVP Strategic Portfolio MgmtForm 4 sale18,910$26k4.5%Plan not statedSEC
Jun 14, 2011Spink Katharine E.SVP Alliance Mgmt & OperationsForm 4 sale22,591$97k6.4%UnusualSEC
Jun 14, 2011Lebkowski JaneSVP, Chief Scientific OfficerForm 4 sale25,262$108k4.3%UnusualSEC
Jun 14, 2011Kelsey Stephen MichaelEVP, R&D Head, CMOForm 4 sale4,858$21k1.0%Plan not statedSEC
Jun 14, 2011Behrs Melissa KellySVP Strategic Portfolio MgmtForm 4 sale25,262$108k5.6%UnusualSEC
Jun 14, 2011Greenwood DavidPresident, Interim CEO, CFOForm 4 sale34,005$146k4.3%UnusualSEC
Jun 14, 2011Earp DavidChief Legal CounselForm 4 sale25,262$108k4.9%UnusualSEC
Jun 14, 2011Bloom Olivia KyusukVP, Chief Acctg OfficerForm 4 sale6,997$30k4.2%Plan not statedSEC
May 24, 2011Bloom Olivia KyusukVP, Chief Acctg OfficerForm 4 sale1,200$5k0.7%Plan not statedSEC
May 24, 2011Spink Katharine E.SVP Prgm Mgmt, Cell TherapiesForm 4 sale419$2k0.1%Plan not statedSEC
May 24, 2011Behrs Melissa KellySVP Strategic Portfolio MgmtForm 4 sale2,975$13k0.7%Plan not statedSEC
May 24, 2011Earp DavidSVP Bus Dev, Chief Patnt CounsForm 4 sale2,975$13k0.6%Plan not statedSEC
May 24, 2011Lebkowski JaneSVP, Chief Scientific OfficerForm 4 sale2,975$13k0.5%Plan not statedSEC
May 24, 2011Greenwood DavidPresident, Interim CEO, CFOForm 4 sale4,462$20k0.6%Plan not statedSEC
May 5, 2011Kelsey Stephen MichaelEVP, CMO, OncologyForm 4 sale14,163$68k3.7%Plan not statedSEC
Jun 2, 2010Spink Katharine E.VP Operations, Regen Med ProgsForm 4 sale8,186$44k8.2%UnusualSEC
Jun 2, 2010Lebkowski JaneSVP, CSO Regen MedForm 4 sale10,617$58k5.1%Plan not statedSEC
Jun 2, 2010Behrs Melissa KellySVP OncologyForm 4 sale10,617$58k7.2%Plan not statedSEC
Jun 2, 2010Earp DavidSVP Bus Dev, Chief Patnt CounsForm 4 sale10,617$58k5.0%Plan not statedSEC
Jun 2, 2010Greenwood DavidEVP and CFOForm 4 sale14,746$80k5.4%Plan not statedSEC
Jun 2, 2010Okarma ThomasPresident and CEOForm 4 sale18,874$102k4.1%Plan not statedSEC
May 24, 2010Spink Katharine E.VP Operations, Regen Med ProgsForm 4 sale385$2k0.4%Plan not statedSEC
May 24, 2010Lebkowski JaneSVP, CSO Regen MedForm 4 sale2,336$12k1.1%Plan not statedSEC
May 24, 2010Behrs Melissa KellySVP OncologyForm 4 sale2,336$12k1.6%Plan not statedSEC
May 24, 2010Earp DavidSVP Bus Dev, Chief Patnt CounsForm 4 sale2,336$12k1.1%Plan not statedSEC
May 24, 2010Greenwood DavidEVP and CFOForm 4 sale3,503$18k1.3%Plan not statedSEC
May 24, 2010Okarma ThomasPresident and CEOForm 4 sale4,671$24k1.0%Plan not statedSEC
Apr 28, 2010Kelsey Stephen MichaelEVP, CMO, OncologyForm 4 sale3,707$21k9.3%Plan not statedSEC
May 29, 2009Spink Katharine E.VP Operations, Regen Med ProgsForm 4 sale400$3k3.8%Plan not statedSEC
May 29, 2009Okarma ThomasPresident and CEOForm 4 sale5,828$37k1.9%Plan not statedSEC
May 29, 2009Lebkowski JaneSVP, CSO Regen MedForm 4 sale2,277$14k1.9%Plan not statedSEC
May 29, 2009Behrs Melissa KellySVP OncologyForm 4 sale2,277$14k3.7%Plan not statedSEC
May 29, 2009Harley CalvinVP, CSO Telomerase TechForm 4 sale2,277$14k3.2%Plan not statedSEC
May 29, 2009Earp DavidSVP Bus Dev, Chief Patnt CounsForm 4 sale2,277$14k1.8%Plan not statedSEC
May 29, 2009Greenwood DavidEVP and CFOForm 4 sale3,416$22k2.2%Plan not statedSEC
May 29, 2009Benedetti Fabio MSVP, Chief Med Off, OncologyForm 4 sale2,277$14k5.6%Plan not statedSEC
May 26, 2009Spink Katharine E.VP Operations, Regen Med ProgsForm 4 sale2,864$19k21.4%Plan not statedSEC
May 26, 2009Okarma ThomasPresident and CEOForm 4 sale46,669$315k13.2%Plan not statedSEC
May 26, 2009Behrs Melissa KellySVP OncologyForm 4 sale6,819$46k10.0%Plan not statedSEC
May 26, 2009Lebkowski JaneSVP, CSO Regen MedForm 4 sale14,092$95k10.3%Plan not statedSEC
May 26, 2009Harley CalvinVP, CSO Telomerase TechForm 4 sale10,001$68k12.3%Plan not statedSEC
May 26, 2009Greenwood DavidEVP and CFOForm 4 sale19,320$130k11.0%Plan not statedSEC
May 26, 2009Earp DavidSVP Bus Dev, Chief Patnt CounsForm 4 sale15,456$104k10.7%Plan not statedSEC
Apr 3, 2009Benedetti Fabio MSVP, Chief Med Off, OncologyForm 4 sale5,195$23k11.4%Plan not statedSEC
Feb 2, 2009Behrs Melissa KellySVP OncologyForm 4 sale14,765$120k100.0%UnusualSEC
Jan 30, 2009Walker John PeterDirectorForm 4 sale48,617$403k55.4%UnusualSEC
Jan 29, 2009Harley CalvinVP and CSOForm 4 sale30,489$216k23.5%UnusualSEC
Jan 5, 2009Okarma ThomasPresident and CEOForm 4 sale12,512$61k3.4%Plan not statedSEC
Jan 5, 2009Lebkowski JaneSVP Regen MedicineForm 4 sale8,861$43k5.6%Plan not statedSEC
Jan 5, 2009Behrs Melissa KellySVP OncologyForm 4 sale8,861$43k10.0%Plan not statedSEC
Jan 5, 2009Harley CalvinVP and CSOForm 4 sale8,861$43k6.6%Plan not statedSEC
Jan 5, 2009Greenwood DavidEVP and CFOForm 4 sale10,732$53k5.6%Plan not statedSEC
Jan 5, 2009Earp DavidSVP Bus Dev, Chief Patnt CounsForm 4 sale8,861$43k5.4%Plan not statedSEC
Nov 5, 2008Behrs Melissa KellySVP OncologyForm 4 sale23,845$97k21.2%Plan not statedSEC
Jan 4, 2008Okarma ThomasPresident and CEOForm 4 sale13,166$70k3.5%Plan not statedSEC
Jan 4, 2008Lebkowski JaneSVP Regen MedicineForm 4 sale8,911$48k5.7%Plan not statedSEC
Jan 4, 2008Behrs Melissa KellySVP OncologyForm 4 sale8,911$48k8.6%Plan not statedSEC
Jan 4, 2008Harley CalvinVP and CSOForm 4 sale8,911$48k6.9%Plan not statedSEC
Jan 4, 2008Greenwood DavidEVP and CFOForm 4 sale11,039$59k6.0%Plan not statedSEC
Jan 4, 2008Earp DavidSVP Bus Dev, Chief Patnt CounsForm 4 sale8,911$48k5.4%Plan not statedSEC
Nov 12, 2007Greenwood DavidEVP and CFOForm 4 sale4,000$29k2.2%Plan not statedSEC
May 18, 2007Harley CalvinVP and CSOForm 4 sale30,000$276k34.4%UnusualSEC
Jan 9, 2006Behrs Melissa KellyVP, OncologyForm 4 sale8,441$72k53.4%UnusualSEC
Jan 9, 2006Lebkowski JaneSVP, Regenerative MedicineForm 4 sale10,676$91k35.7%UnusualSEC
Jan 9, 2006Okarma ThomasPresident and CEOForm 4 sale12,320$105k28.1%UnusualSEC
Jan 9, 2006Harley CalvinChief Scientific OfficerForm 4 sale9,183$79k53.3%UnusualSEC
Jan 9, 2006Greenwood DavidExecutive VP and CFOForm 4 sale12,183$104k41.8%UnusualSEC
Jan 9, 2006Earp DavidSVP Bus Dev / Chf Patent CounsForm 4 sale11,323$97k35.7%UnusualSEC